-
Something wrong with this record ?
Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations
J. Tužil, J. Matějka, MA. Mamas, T. Doležal
Language English Country England, Great Britain
Document type Systematic Review, Meta-Analysis, Journal Article
- MeSH
- Femoral Artery MeSH
- Radial Artery MeSH
- Stroke * epidemiology etiology prevention & control MeSH
- Percutaneous Coronary Intervention * methods MeSH
- Humans MeSH
- Catheterization, Peripheral * methods MeSH
- Prospective Studies MeSH
- Risk Factors MeSH
- Cardiac Catheterization adverse effects methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Systematic Review MeSH
OBJECTIVES: To verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS). METHODS: We reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA). RESULTS: The pooled incidence of PS from 2,188,047 catheterizations (14 cohorts), was 193 (105 to 355) per 100,000. Meta-analyses of adjusted estimates (OR = 0.66 (0.49 to 0.89); p = 0.007; I2 = 90%), unadjusted estimates (OR = 0.63 (0.51 to 0.77; I2 = 74%; p = 0.000)), and a sub-group of prospective cohorts (OR = 0.67 (0.48 to 0.94; p = 0.022; I2 = 16%)) had a lower risk of PS in TRA (without indication of publication bias). SSA confirmed the pooled sample size was sufficient to support these conclusions. Meta-regression decreased the unexplained heterogeneity but did not identify any independent predictor of PS nor any effect modifier. CONCLUSION: Periprocedural stroke remains a rare and hard-to-predict adverse event associated with cardiac catheterization. TRA is associated with a 20% to 30% lower risk of PS in real-world/common practice settings. Future studies are unlikely to change our conclusion.
Biomedical informatics 1st Medical Faculty Charles University Prague Czech Republic
Department of Cardiology Hospital of Pardubice Pardubice Czech Republic
Faculty of Health Studies University of Pardubice Pardubice Czech Republic
Keele Cardiovascular Research Group University of Keele StokeonTrent UK
Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010541
- 003
- CZ-PrNML
- 005
- 20230801132504.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/14779072.2023.2187378 $2 doi
- 035 __
- $a (PubMed)36877129
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Tužil, Jan $u Value Outcomes s.r.o., Prague, Czech Republic $u Biomedical informatics, First Medical Faculty, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000271824010
- 245 10
- $a Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations / $c J. Tužil, J. Matějka, MA. Mamas, T. Doležal
- 520 9_
- $a OBJECTIVES: To verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS). METHODS: We reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA). RESULTS: The pooled incidence of PS from 2,188,047 catheterizations (14 cohorts), was 193 (105 to 355) per 100,000. Meta-analyses of adjusted estimates (OR = 0.66 (0.49 to 0.89); p = 0.007; I2 = 90%), unadjusted estimates (OR = 0.63 (0.51 to 0.77; I2 = 74%; p = 0.000)), and a sub-group of prospective cohorts (OR = 0.67 (0.48 to 0.94; p = 0.022; I2 = 16%)) had a lower risk of PS in TRA (without indication of publication bias). SSA confirmed the pooled sample size was sufficient to support these conclusions. Meta-regression decreased the unexplained heterogeneity but did not identify any independent predictor of PS nor any effect modifier. CONCLUSION: Periprocedural stroke remains a rare and hard-to-predict adverse event associated with cardiac catheterization. TRA is associated with a 20% to 30% lower risk of PS in real-world/common practice settings. Future studies are unlikely to change our conclusion.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a koronární angioplastika $x metody $7 D062645
- 650 12
- $a cévní mozková příhoda $x epidemiologie $x etiologie $x prevence a kontrola $7 D020521
- 650 _2
- $a srdeční katetrizace $x škodlivé účinky $x metody $7 D006328
- 650 _2
- $a arteria radialis $7 D017534
- 650 _2
- $a arteria femoralis $7 D005263
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a periferní katetrizace $x metody $7 D002406
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Matějka, Jan $u Department of Cardiology, Hospital of Pardubice, Pardubice, Czech Republic $u Faculty of Health Studies, University of Pardubice, Pardubice, Czech Republic $u Academic Department of Internal Medicine, Charles University Faculty of Medicine, Hradec Králové, Czech Republic
- 700 1_
- $a Mamas, Mamas A $u Keele Cardiovascular Research Group, University of Keele, StokeonTrent, UK $1 https://orcid.org/0000000192418890
- 700 1_
- $a Doležal, Tomáš $u Value Outcomes s.r.o., Prague, Czech Republic $u Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00174406 $t Expert review of cardiovascular therapy $x 1744-8344 $g Roč. 21, č. 4 (2023), s. 293-304
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36877129 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132500 $b ABA008
- 999 __
- $a ok $b bmc $g 1963143 $s 1196806
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 21 $c 4 $d 293-304 $e 20230307 $i 1744-8344 $m Expert review of cardiovascular therapy $n Expert Rev Cardiovasc Ther $x MED00174406
- LZP __
- $a Pubmed-20230718